Effect of Metformin on Circulating Levels of Inflammatory Markers in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

CONCLUSION: The present study evidences that therapy with metformin can reduces CRP level significantly in T2D patients compared to other inflammatory markers.
PMID: 33412927 [PubMed - as supplied by publisher]

Source: The Annals of Pharmacotherapy - January 7, 2021 Category: Drugs & Pharmacology Authors: Karbalaee-Hasani A, Khadive T, Eskandari M, Shahidi S, Mosavi M, Nejadebrahimi Z, Khalkhali L, Sangdari A, Mohammadi D, Soltani A, Khodabandehloo H, Hosseini H, Koushki M Tags: Ann Pharmacother Source Type: research